RVPH Projected Dividend Yield
Reviva Pharmaceuticals Holdings Inc ( NASDAQ : RVPH )Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company. Co. discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. Co.'s pipeline focuses on the central nervous system, respiratory and metabolic diseases. Its pipeline includes two drug candidates, RP5063 (brilaroxazine) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. 20 YEAR PERFORMANCE RESULTS |
RVPH Dividend History Detail RVPH Dividend News RVPH Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |